Shlansky-Goldb Richard MD Philadelphia, PA - 19104

Shlansky-Goldb Richard MD is categorized under Internal Medicine Doctors in Philadelphia, PA and active since 2010.

Shlansky-Goldb Richard MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Richard Shlansky-Goldb at the company’s single location by writing to 3400 Spruce St, Philadelphia, Pennsylvania PA 19104 or by phoning (215) 662-4034. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Shlansky-Goldb Richard MD
Contact Person: Richard Shlansky-Goldb
Address: 3400 Spruce St, Philadelphia, Pennsylvania 19104
Phone Number: (215) 662-4034
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Shlansky-Goldb Richard MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Richard Shlansky-Goldb for inquiries that concern Shlansky-Goldb Richard MD by calling the company number (215) 662-4034, as your correspondence is most welcome. Additionally, the physical location of the single location of Shlansky-Goldb Richard MD can be found at the coordinates 39.950406,-75.192678 as well as the street address 3400 Spruce St in Philadelphia, Pennsylvania 19104.

For its online presence, you may visit Shlansky-Goldb Richard MD’s website at and engage with its social media outlets through on Twitter and on Facebook.